Omer Jamy

机构：University of Alabama at Birmingham Hospital, University of Alabama at Birmingham · ORCID：0000-0003-2411-4742

发表论文 196 篇 · 总被引 1727 次 · h-index 18

代表论文

CARDINAL: A Phase 1 study of TERN-701, a novel investigational allosteric BCR::ABL1 inhibitor for patients with previously treated CML (2025 · Blood · 被引 5)
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias (2026 · Blood Advances · 被引 4)
American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults (2026 · Blood Advances · 被引 3)
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL (2026 · Blood · 被引 3)
Landscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice (2026 · Medical Sciences · 被引 2)
Patient characteristics, toxicity, and response after real world administration of obecabtagene autoleucel and brexucabtagene autoleucel for relapsed acute lymphoblastic leukemia: A rocca analysis (2025 · Blood · 被引 2)